Trending News Today: Inflammatory Bowel Diseases May Increase Risk of Heart Attack

A recent study found that individuals with inflammatory bowel diseases (IBD) may be up to 12 times more likely to have a heart attack, Reuters reported. According to the article, the researchers examined a nationwide database of medical records for more than 29 million individuals, including approximately 132,000 with ulcerative colitis and 159,000 with Crohn disease. The study found that those with IBD were 25% more likely to have a heart attack than those without the disorder, the article reported.
 
Cigna Corp is using artificial intelligence to identify patients who are most likely to abuse prescription opioids, according to The Wall Street Journal. The company developed predictive models from a combination of 16 datasets that included statistics about patients’ behavioral health claims, chronic disease history, and interactions with pharmacies. According to the article, Cigna identified approximately 1130 customers for outreach during a yearlong pilot program that ended in June 2018.
 
Many older adults who are prescribed antidepressants fail to take their medications or continue using them as directed, Reuters reported. The study included data from approximately 1500 individuals who were at least 60 years old and diagnosed with depression in 2012 by primary care providers. Overall, approximately 14% of the patients with depression who were prescribed antidepressants failed to start taking the drugs within 2 weeks, 15% missed doses at least 20% of the time, and 37% stopped altogether within 1 year, according to the article.



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

An inhaled medication for a disease that does not affect the lungs may prove to be a promising concept in the treatment of chronic diseases.
Top news of the day across the health care landscape
Top news of the day across the health care landscape.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$